Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1968 Nov;16(11):1753–1760. doi: 10.1128/am.16.11.1753-1760.1968

Carbenicillin: Activity In Vitro and Absorption and Excretion in Normal Young Men

Charles B Smith 1,2,1, Maxwell Finland 1,2
PMCID: PMC547754  PMID: 4387223

Abstract

Carbenicillin is a new semisynthetic penicillin which differs from other penicillins in showing moderate antibacterial activity against Pseudomonas. Its activity in vitro is enhanced at low pH. Serum binding is of low order and does not appreciably alter activity. Strains of Pseudomonas exposed to subinhibitory concentrations of carbenicillin rapidly develop resistance by a mechanism that does not depend upon destruction of the drug. In normal subjects, high levels of anti-Pseudomonas activity are readily obtained in the urine after intramuscular injection. Levels of carbenicillin adequate to inhibit many strains of Pseudomonas can be achieved in serum only with an intravenous administration of a large dose. Carbenicillin appears to exhibit the same low degree of toxicity as do other penicillins.

Full text

PDF
1760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Brown D. M., Knudsen E. T., Rolinson G. N., Sutherland R. New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967 Jul 1;215(5096):25–30. doi: 10.1038/215025a0. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Terrell L. M. In vitro activity of carbenicillin against gram-negative bacilli. J Bacteriol. 1968 May;95(5):1587–1590. doi: 10.1128/jb.95.5.1587-1590.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brumfitt W., Percival A., Leigh D. A. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967 Jun 17;1(7503):1289–1293. doi: 10.1016/s0140-6736(67)91590-5. [DOI] [PubMed] [Google Scholar]
  4. FINLAND M., JONES W. F., Jr, BARNES M. W. Occurrence of serious bacterial infections since introduction of antibacterial agents. J Am Med Assoc. 1959 Aug 29;170:2188–2197. doi: 10.1001/jama.1959.63010180008012. [DOI] [PubMed] [Google Scholar]
  5. Finland M., Kirby W. M., Chabbert Y. A., Chain E. B., Dowling H. F., Garrod L. P., Pettinga C. W., Todd A. C. Round table: are new antibiotics needed? Antimicrob Agents Chemother (Bethesda) 1965;5:1107–1114. [PubMed] [Google Scholar]
  6. HERSH E. M., BODEY G. P., NIES B. A., FREIREICH E. J. CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963. JAMA. 1965 Jul 12;193:105–109. doi: 10.1001/jama.1965.03090020019005. [DOI] [PubMed] [Google Scholar]
  7. Jones R. J., Lowbury E. J. Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. Br Med J. 1967 Jul 8;3(5557):79–82. doi: 10.1136/bmj.3.5557.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KLEIN J. O., FINLAND M. Ampicillin activity in vitro and absorption and excretion in normal young men. Am J Med Sci. 1963 May;245:544–555. [PubMed] [Google Scholar]
  9. KLEIN J. O., FINLAND M. THE NEW PENICILLINS. N Engl J Med. 1963 Nov 14;269:1074–CONTD. doi: 10.1056/NEJM196311142692006. [DOI] [PubMed] [Google Scholar]
  10. Kessner D. M., Lepper M. H. Epidemiologic studies on gram-negative bacilli in the hospital and community. Am J Epidemiol. 1967 Jan;85(1):45–60. doi: 10.1093/oxfordjournals.aje.a120674. [DOI] [PubMed] [Google Scholar]
  11. Knudsen E. T., Rolinson G. N., Sutherland R. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea. Br Med J. 1967 Jul 8;3(5557):75–78. doi: 10.1136/bmj.3.5557.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pines A., Raafat H., Plucinski K. Gentamicin and colistin in chronic purulent bronchial infections. Br Med J. 1967 May 27;2(5551):543–545. doi: 10.1136/bmj.2.5551.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Steigbigel N. H., McCall C. E., Reed C. W., Finland M. Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci. 1967 Sep 27;145(2):224–236. doi: 10.1111/j.1749-6632.1967.tb50221.x. [DOI] [PubMed] [Google Scholar]
  14. Van Rooyen C. E., Ross J. F., Bethune G. W., MacDonald A. C. Bacteriological observations on carbenicillin in the control of Pseudomonas aeruginosa infection in burns. Can Med Assoc J. 1967 Nov 11;97(20):1227–1229. [PMC free article] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES